< Back to latest news & events

AGRITECH + IP

The Strawberry Patent Battle: Seeds, Speculation, and Jurisdiction

June 2025

 

This case, relating to infringement of a US plant patent, deals with the evidentiary burden required to show infringement of a plant patent in the US, as well as highlighting the problems associated with asserting IP rights in relation to breeding programs conducted across different jurisdictions.

A US plant patent provides protection for asexually produced plants (apart from tuber propagated plants and uncultivated plants).  A plant patent owner has the right to exclude third parties from “asexually reproducing the plant, and from using, offering for sale, or selling the plant so reproduced, or any of its parts, throughout the United States, or from importing the plant so reproduced, or any parts thereof, into the United States.”  Notably, in contrast to plant variety rights, a plant patent does not provide protection against unauthorised export of the protected plant.

The case relates to the breeding of strawberries, with the patentee (Driscoll) in 2019 alleging that California Berry Cultivars (CBC) had infringed three of their US plant patents, firstly by cross-breeding the patented varieties in Spain, and then secondly by importing seed derived from the cross-breeding program into the US.

In strawberries, the male plant provides the pollen, and the female plant produces the fruit and seeds.  However, most strawberry flowers include both male and female reproductive parts, and so in a cross-breeding event, any single variety could be used as either the male or the female parent.

Driscoll’s allegation relating to infringement as a result of unauthorised importation of seed was based on the argument that their patented plants were used as female plants for crossbreeding, and therefore the seeds imported in the US were a “part” of a patented plant.  To support this allegation, they needed to provide evidence as to which variety was used as the female in each cross.  However, the CBC’s breeding plans did not specify which variety was used as the female in each cross, and there was no evidence of how each cross was performed.  The Judge found that Driscoll relied on “guesswork and speculation” regarding the parents in the cross-breeding, and had failed to meet its evidentiary burden in showing that the seed was indeed a ‘part’ of one of their protected varieties.  The Judge remarked that “the mere existence of progeny of a patented plant does not support an inference that that Defendants imported and used seeds that were grown on a Patented Plant, as opposed to the other variety in any given cross”. 

The Judge further dismissed the allegation of infringement based on cross-breeding because this activity was performed in Spain and therefore outside of the jurisdiction of Driscoll’s US plant patents.

Breeding programs often take place across multiple jurisdictions, and the protection afforded can differ between patents, plant patents, and plant variety rights.  This case again highlights the complexities in adequately protecting innovation in this sector, the challenges in obtaining evidence relating to third-party activities, and protecting the rights of breeders.


This article was written by Partner & Patent Attorney Punita Shah, and Trainee Patent Attorney Delphine Lauté-Caly.

Latest updates

Empowered, Not Replaced: The Risks and Rewards of Using AI Tools in Patent Prosecution

With the rapid rise of AI and extreme hype around generative AI tools in the workplace, patent firms around the world have had to seriously consider to what extent they …

Read article

EU Agrees on NGT Plant Regulation: What It Means for Patents and Licensing

The European Parliament and Council have reached a provisional agreement for plants developed using New Genomic Techniques (NGTs) – below we summarise the main points and set out the requirements …

Read article

When Retail Branding Meets Politics

(Inter IKEA Systems v Algemeen Vlaams Belang (Case C‑298/23) In November 2022, the Flemish political party Vlaams Belang presented its “IKEA-PLAN – Immigratie Kan Echt Anders” (“Immigration Really Can Be Different”). …

Read article

Office Closed Dates December 2025 / January 2026

HGF Office Closed Dates December 2025 / January 2026   UK Thursday 25 and Friday 26 December 2025 CLOSED Thursday 1 January 2026* CLOSED * Friday 2 January 2026 – …

Read article

Often Copied, Never Equaled: When Do Everyday Items Become Subject of Copyright?

The  borderline between ‘pure’ works of art and mere utilitarian objects” –  Can iconic, yet everyday products be protected under copyright? The above question was posed by Advocate General in …

Read article

T 0883/23: Dosage claims and their entitlement to priority when only the clinical trial protocol was disclosed in the priority application

In a recently issued decision by the EPO’s Board of Appeal (BoA), the BoA held that claims directed to a combination of active pharmaceutical ingredients (APIs) at particular doses were …

Read article

The end of the Brexit overhang for trade marks: review, refile and revoke.

On the 31st December 2025, five years will have passed since the end of the Brexit transitional period on 31st December 2020. Why is this relevant? For UK cloned trade …

Read article
Event - 14th January 2026

Seminar on The aftermath of G1/24 - has anything changed?

HGF is hosting a The aftermath of G1/24 – has anything changed? Which will be followed by networking, apero, and snacks. The Seminar will be held on Wednesday, 14th January …

Event details